Trial Profile
Phase II study of Kynurenic acid (FS2) prevention of post-surgical scar formation
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 08 Feb 2019
Price :
$35
*
At a glance
- Drugs Kynurenic acid (Primary)
- Indications Scars
- Focus Adverse reactions; Therapeutic Use
- 05 Feb 2019 According to a BirchBioMed media release, the company poised to begin patient enrollment in this study.
- 21 Feb 2018 New trial record
- 16 Feb 2018 According to a BirchBioMed media release, the company got clearance by Health Canada to begin a phase II clinical trial of FS2.